Other Assets, Noncurrent in USD of Larimar Therapeutics, Inc. from Q4 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Larimar Therapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2013 to Q3 2025.
  • Larimar Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $542K, a 12.7% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Larimar Therapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $542K -$79K -12.7% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $561K -$75K -11.8% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $582K -$96K -14.2% 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $596K -$63K -9.56% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $621K -$13K -2.05% 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 $636K -$8K -1.24% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $678K +$46K +7.28% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $659K +$21K +3.29% 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 $634K -$9K -1.4% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $644K -$5K -0.77% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $632K -$36K -5.39% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $638K -$31K -4.63% 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 $643K -$28K -4.17% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $649K -$23K -3.42% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $668K -$82K -10.9% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $669K +$250K +59.7% 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $671K +$593K +760% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $672K +$592K +740% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $750K +$738K +6150% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $419K +$329K +366% 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 $78K +$58K +290% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $80K +$60K +300% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $12K -$45K -78.9% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $90K +$33K +57.9% 31 Dec 2019 10-K 04 Mar 2021
Q3 2019 $20K -$37K -64.9% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $20K -$337K -94.4% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $57K -$75K -56.8% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $57K $0 0% 31 Dec 2018 10-K 05 Mar 2020
Q3 2018 $57K $0 0% 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 $357K +$299K +516% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $132K +$73K +124% 31 Mar 2018 10-Q 10 May 2018
Q4 2017 $57K -$4K -6.56% 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 $57K -$27K -32.1% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $58K -$29K -33.3% 30 Jun 2017 10-Q 09 Aug 2017
Q1 2017 $59K -$31K -34.4% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $61K -$33K -35.1% 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $84K +$5K +6.33% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $87K +$3K +3.57% 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 $90K +$1K +1.12% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $94K -$148K -61.2% 31 Dec 2015 10-K 10 Mar 2017
Q3 2015 $79K -$19K -19.4% 30 Sep 2015 10-Q 13 Nov 2015
Q2 2015 $84K -$20K -19.2% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 $89K 31 Mar 2015 10-Q 14 May 2015
Q4 2014 $242K -$501K -67.4% 31 Dec 2014 10-K 15 Mar 2016
Q3 2014 $98K 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 $104K 30 Jun 2014 10-Q 14 Aug 2014
Q4 2013 $743K 31 Dec 2013 10-K 25 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.